Squarepoint Ops LLC Biomarin Pharmaceutical Inc Call Options Transaction History

Squarepoint Ops LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $3.44 Million - $4.68 Million	49,900 Added 110.64%	95,000 $6.68 Million
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $3.16 Million - $3.92 Million	42,500 Added 1634.62%	45,100 $3.71 Million
Q1 2024 May 15, 2024	SELL	$83.81 - $99.0 $2.31 Million - $2.73 Million	-27,600 Reduced 91.39%	2,600 $227,000
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $2.3 Million - $2.98 Million	30,200 New	30,200 $2.91 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $437,492 - $557,967	6,100 New	6,100 $539,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.